Evidence map›Paper›PMID 32445134›Full record

ReviewOphthalmology and therapy2020

COVID-19 Disease and Ophthalmology: An Update.

María A Amesty, Jorge L Alió Del Barrio, Jorge L Alió

Open access · goldAbstract readReview
In one paragraph

Review in Ophthalmology and therapy, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
11.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 73 citations in OpenAlex.

  1. Observational
  2. [Ophthalmic manifestations in patients recovered from COVID-19 in Mexico].Archivos de la Sociedad Espanola de Oftalmologia · 2023
    Article
  3. Ophthalmic manifestations in patients recovered from COVID-19 in Mexico.Archivos de la Sociedad Espanola de Oftalmologia · 2023
    Observational
  4. Article
  5. Article
  6. Article
  7. Article
  8. Journal francais d'ophtalmologie · 2021
    Article
  9. COVID-19 ocular findings in children: a case series.World journal of pediatrics : WJP · 2021
    Observational
  10. Review
  11. Article
  12. Article
  13. Ophthalmic manifestations associated with SARS-CoV-2 in newborn infants: a preliminary report.Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus · 2021
    Article
  14. Article
  15. Ocular Involvement of SARS-CoV-2 in a Polish Cohort of COVID-19-Positive Patients.International journal of environmental research and public health · 2021
    Article
  16. Article
  17. Systemic diseases and the cornea.Experimental eye research · 2021
    Review
  18. Conjunctivitis and COVID-19: The importance of early recognition by the physician.Enfermedades infecciosas y microbiologia clinica (English ed.) · 2021
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

María A AmestyOculoplastic Department, Vissum (Grupo Miranza), Alicante, Spain.
Jorge L Alió Del BarrioCornea, Cataract and Refractive Surgery Unit, Vissum (Grupo Miranza), Alicante, Spain.
Jorge L AlióCornea, Cataract and Refractive Surgery Unit, Vissum (Grupo Miranza), Alicante, Spain. jlalio@vissum.com.
Miranza · ESUniversitat de Miguel Hernández d'Elx · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The worldwide outbreak of the severe and acute respiratory coronavirus disease (COVID-19) caused by the coronavirus strain SARS-CoV-2 is currently the focal point of discussion due to the suffering this syndrome is causing to humanity. However, the ophthalmological implications of this syndrome has not yet been well described. Both eyes and tears as portals of entry and sources of contagion have been the subject of debate by many authors. The purpose of this review is to summarize the evidence currently available on COVID-19 and its ocular implications and manifestations, in both animals and humans, with the aim to facilitate prevention and educate the ophthalmological community on this subject. A review of the literature revealed that the results of some studies suggest that ocular symptoms commonly appear in patients with severe COVID-19 pneumonia and that it is possible to isolate the virus from the conjunctival sac of these patients. Conjunctivitis is not a common manifestation of the disease, but contact with infected eyes could be one route of transmission. Consequently, ophthalmologists need to have correct prevention strategies in place. Some guidelines regarding the prevention and management of ophthalmology clinics are reviewed. However, well-designed trials should be conducted to rule out other ocular manifestations that may result from COVID-19 infection and to understand the transmission of the virus through the eyes.

Indexed as

ConjunctivitisCoronavirusCOVID-1Ocular transmissionOphthalmologySARS-CoV-2

Identifiers

PMID32445134
PMCPMC7243216
OpenAlexW3026214541

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.